Recurrent/ Metastatic Endometrial Carcinoma
1 clinical trials · Condition
◉ Watch Recurrent/ Metastatic Endometrial Carcinoma
| Record | Firm | Date |
|---|---|---|
| A Study of Pembrolizumab in Combination With Epacadostat in Women With Recurrent/Metastatic Endometrial Carcinoma (NCT03310567) | Fox Chase Cancer Center | 2018-09-01 |
Track Recurrent/ Metastatic Endometrial Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.